More Mid-Cap Biotech M&A May Be Coming

By: via Benzinga
More biotech mergers may be coming. In a new report, Citi analyst Yigal Nochomovitz takes a look at buyout opportunities in the ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.